03.01.2017 19:03:00
|
Faruqi & Faruqi, LLP is Investigating UnitedHealth Group Incorporated (UNH) on Behalf of its Shareholders
NEW YORK, Jan. 3, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at UnitedHealth Group Incorporated ("United Health" or the "Company") (NYSE:UNH).
The investigation focuses on whether the Company's Board of Directors and its officers committed mismanagement and breached their fiduciary duties. On October 4, 2016, the first of several class action complaints was filed in the United States District Court, District of Minnesota, against United Health and several of its wholly-owned subsidiaries (the "United Health Defendants") alleging violations of (a) the Employee Retirement Income Security Act of 1974 ("ERISA"), (b) violations of state law and (c) violations of the Racketeering Influenced and Corrupt Organizations Act ("RICO"). The complaint alleged that the United Health Defendants required network pharmacies to charge insured patients unauthorized and excessive amounts for prescription drugs. The United Health Defendants "clawed back" these excessive payments by forcing the pharmacies to pay the unauthorized and excessive charges to the United Health Defendants after collecting them from the insureds.
Request more information now by clicking here: www.faruqilaw.com/UNH. There is no cost or obligation to you.
Take Action
If you currently own United Health stock and would like to discuss your legal rights, please visit www.faruqilaw.com/UNH. You can also contact us by calling Nina Varindani toll free at (212) 983-9330 or by sending an e-mail to nvarindani@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding United Health's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 3rd Avenue, 26th Floor
New York, NY 10017
Attn: Nina Varindani
nvarindani@faruqilaw.com
Telephone: (212) 983-9330
Attn: Stuart J. Guber
sguber@faruqilaw.com
Telephone: (215) 277-5770
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-unitedhealth-group-incorporated-unh-on-behalf-of-its-shareholders-300384784.html
SOURCE Faruqi & Faruqi, LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu UnitedHealth Inc.mehr Nachrichten
03.01.25 |
Dow Jones-Handel aktuell: Dow Jones beendet die Freitagssitzung in der Gewinnzone (finanzen.at) | |
03.01.25 |
Freitagshandel in New York: Dow Jones präsentiert sich fester (finanzen.at) | |
03.01.25 |
NYSE-Handel: Dow Jones am Freitagmittag stärker (finanzen.at) | |
03.01.25 |
Dow Jones 30 Industrial-Papier UnitedHealth-Aktie: Hätte sich ein Investment in UnitedHealth vor 3 Jahren inzwischen bezahlt gemacht? (finanzen.at) | |
03.01.25 |
Börse New York: Dow Jones zum Start mit positivem Vorzeichen (finanzen.at) | |
01.01.25 |
Erste Schätzungen: UnitedHealth stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
30.12.24 |
Montagshandel in New York: Dow Jones verbucht zum Ende des Montagshandels Verluste (finanzen.at) | |
27.12.24 |
Dow Jones 30 Industrial-Papier UnitedHealth-Aktie: So viel Verlust hätte eine UnitedHealth-Investition von vor einem Jahr eingebracht (finanzen.at) |
Analysen zu UnitedHealth Inc.mehr Analysen
Aktien in diesem Artikel
UnitedHealth Inc. | 498,00 | 0,00% |